Skip to content

LENSAR, Inc. LNSR Free cash flow margin

Free cash flow margin at other companies

Johnson & Johnson logo
Johnson & JohnsonJNJ
18.5%-4.3pp
Staar Surgical logo
Staar SurgicalSTAA
-19.6%+55.9pp
Bausch + Lomb logo
Bausch + LombBLCO
-3.4%0.0pp
ClearPoint Neuro logo
ClearPoint NeuroCLPT
-65.7%+269pp
IAR
Integra LifeSciencesIART
3.8%-6.3pp
ITG
Integer HoldingsITGR
5.4%-1.0pp

Other financials

Income statement

See full
Revenue$13.4M-5.2%
Gross profit$6.4M-10.4%
Operating income$2.2M+139%
Net income$36.3M+233%
EPS (diluted)$0.00+100%

Balance sheet

See full
Cash & equivalents$12.5M-36.1%
Total debt$7.6M+206%
Total equity$10.8M+149%
Total assets$66.2M-9.2%

Cash flow

See full
Operating cash flow-$4.3M+38.4%
CapEx$77.0K-31.9%
Free cash flow-

Valuation

See full
Market cap$70.13M-53.1%
Enterprise value$65.21M-54.9%
P/E2.4×
P/S1.2×-1.3×

Profitability

See full
Gross margin45.7%-2.1pp
Operating margin-28.7%+7.3pp
Net margin50.9%+30.7pp

Returns & leverage

See full
Return on equity-164%-235pp
Debt / equity0.7×
Current ratio2.4×+0.6×

Where this comes from

Calculated from LENSAR, Inc.’s reported figures.

Based on trailing twelve months.

The official record: LENSAR, Inc.’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about LENSAR, Inc.'s free cash flow margin.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is LENSAR, Inc.'s free cash flow margin?
LENSAR, Inc. (LNSR) reported free cash flow margin of -26.6% in Q4 2025.
What is the long-term trend for LENSAR, Inc.'s free cash flow margin?
Over 4 years (2020 to 2025), LENSAR, Inc.'s free cash flow margin has grown at a -16.1% compound annual growth rate (CAGR), from -53.7% to -26.6%.
What does free cash flow margin mean?
Free cash flow (operating cash flow minus capital expenditures) as a percentage of revenue, trailing twelve months. Measures how efficiently revenue converts into discretionary cash.